Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 29.36
+0.38 (1.31%)
At close: Mar 6, 2026
SHE:002880 Market Cap
SHE:002880 has a market cap or net worth of 6.66 billion as of March 6, 2026. Its market cap has increased by 9.55% in one year.
Market Cap
6.66B
Enterprise Value
7.30B
Revenue
1.14B
Ranking
n/a
PE Ratio
29.12
Stock Price
29.36
Market Cap Chart
Since June 16, 2017, SHE:002880's market cap has increased from 3.91B to 6.66B, an increase of 70.51%. That is a compound annual growth rate of 6.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 6.57B | 13.65% |
| Dec 31, 2025 | 5.78B | -5.59% |
| Dec 31, 2024 | 6.13B | -23.11% |
| Dec 29, 2023 | 7.97B | 10.16% |
| Dec 30, 2022 | 7.23B | -0.90% |
| Dec 31, 2021 | 7.30B | -6.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 7.60B |
| Suzhou Fengbei Biotech Stock | 7.52B |
| Acrobiosystems | 7.29B |
| Wuhan Keqian Biology Co.,Ltd | 7.18B |
| Jiangsu Aidea Pharmaceutical Group | 7.15B |
| R&G PharmaStudies | 6.26B |
| Lifecome Biochemistry | 6.23B |
| Beijing Konruns Pharmaceutical | 6.22B |